-
The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
Southern Finance and Economics, September 27th - Sanofi announced that Dabitou& reg; Dupilumab injection has been approved by the National Medical Products Administration (NMPA) of China for use in a ... -
Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ...